CRISPR 2.0 tools such as base and prime editing rewrite DNA with precision, avoiding breaks. They’ve led to approved therapies like Casgevy for sickle cell disease, yet ethical and access challenges remain.
Avengers: Doomsday brings Robert Downey Jr. back to Marvel, but as Doctor Doom,can Marvel turn its greatest hero into its greatest villain?
The EU, US, and China are racing to regulate AI, but legislation struggles to keep up with rapid advances. Striking a balance between safety and innovation while avoiding regulatory capture remains the key challenge.
Wearables convert the body into a continuous data source that enables early diagnosis and tailored health recommendations, yet they raise urgent privacy issues: sensitive physiological data is often left unprotected and monetized.
The future is hybrid: open source AI fuels innovation and privacy, proprietary models lead in capability and safety, and regulation will shape the balance between them.
AI agents are evolving from passive chatbots into proactive systems that autonomously complete complex tasks. They promise significant productivity gains, but their adoption demands careful attention to safety, reliability, and ethical guardrails.
BCIs are restoring communication and movement for paralyzed individuals while expanding into consumer wellness. This shift promises daily cognitive enhancement but also raises urgent concerns about neural data privacy, safety, and fair access.
Despite large renewable investments, Big Tech’s carbon negative goals are jeopardized by AI’s soaring energy use, rising emissions, and questionable carbon offsets, casting doubt on whether genuine carbon negativity is achievable.
